Bonamour Introduces \akte-vāt\™ Activating Mineral Mist to its Line of Anti-Aging Skincare Products
DALLAS--(BUSINESS WIRE)-- Bonamour, Inc., (OTCQB: BONI) announced today that the Company has introduced \akte-vat\™ Activating Mineral Mist as a new product offering to its line of anti-aging skin care products. \akte-vāt\™ is a weightless mist that is designed to lock in moisture and supply vital nutrients for younger looking skin.
"We are very pleased to introduce \akte-vāt\™ to our line of anti-aging skin care products as we feel it is a complementary addition to our current line of cosmaceuticals and is another effective component in our overall skincare system," said Nathan Halsey, CEO of Bonamour Inc.
The Company plans to introduce \akte-vāt\™ Activating Mineral Mist in certain target markets in Asia in mid-July of 2013.
About Bonamour, Inc.:
Bonamour, Inc. is a Dallas-based developer and brand owner of a high end line of anti-aging skin care products often referred to as cosmeceuticals. The Company's products are marketed and sold through its affiliate and sales arm, Bonamour International, LLC. Bonamour International is focused on building a network marketing and direct sales/distribution organization for the Bonamour brand in Asia. The Company's target markets are comprised of nearly three billion people, many of whom are experiencing rapidly rising personal incomes and a strong affinity for U.S. made luxury goods. For additional information log on to www.bonamour.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, initiatives, goals, strategies and new product introductions; statements of projections regarding international sales targets and goals in Asia including Mainland China; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
-- any changes in operations or future financial results from those currently anticipated;
-- any failure of current or planned initiatives or products to generate interest among distributors and customers and generate sponsoring and selling activities on a sustained basis;
-- risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, including possible ingredient supply limitations;
-- risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;
-- regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;
-- any inability to secure necessary governmental approvals or licenses to effect any future changes or expansion;
-- regulatory scrutiny and investigations in target markets in Asia and other foreign markets, that could in the future, negatively impact the company's business, including the interruption of sales activities in stores, loss of licenses, and the imposition of fines;
-- adverse publicity related to the company's business, products, industry or any legal actions or complaints by distributors or others; and
-- continued competitive pressures in the company's markets.
The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.
Taylor Capital, Inc
Stephen Taylor, 973-351-3868
KEYWORDS: United States Asia Pacific North America Texas
The article Bonamour Introduces \akte-vāt\™ Activating Mineral Mist to its Line of Anti-Aging Skincare Products originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.